Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies.

MLA

Coret, Francisco, et al. “Onset of Secondary Progressive Multiple Sclerosis Is Not Influenced by Current Relapsing Multiple Sclerosis Therapies.” Multiple Sclerosis Journal - Experimental, Translational and Clinical, vol. 4, no. 2, June 2018, p. 2055217318783347. EBSCOhost, https://doi.org/10.1177/2055217318783347.

APA

Coret, F., Pérez-Miralles, F. C., Gascón, F., Alcalá, C., Navarré, A., Bernad, A., Boscá, I., Escutia, M., Gil-Perotin, S., & Casanova, B. (2018). Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies. Multiple Sclerosis Journal - Experimental, Translational and Clinical, 4(2), 2055217318783347. https://doi.org/10.1177/2055217318783347

Chicago

Coret, Francisco, Francisco C Pérez-Miralles, Francisco Gascón, Carmen Alcalá, Arantxa Navarré, Ana Bernad, Isabel Boscá, Matilde Escutia, Sara Gil-Perotin, and Bonaventura Casanova. 2018. “Onset of Secondary Progressive Multiple Sclerosis Is Not Influenced by Current Relapsing Multiple Sclerosis Therapies.” Multiple Sclerosis Journal - Experimental, Translational and Clinical 4 (2): 2055217318783347. doi:10.1177/2055217318783347.